• Subject: RE: Programmers VS Consultants
  • From: PaulMmn <PaulMmn@xxxxxxxxxxxxx>
  • Date: Sat, 27 Nov 1999 00:14:33 -0500

>--snip--
> If, after a few years and many hundreds of millions, the drug is
>> found to be ineffectual, or has serious side affects, it's back to the
>> drawing board and all that money is gone.
>--snip--
>
>Serious side affects... that reminds me of all these commercials for
>heartburn, asthma, etc...
>
>They start out slow...
>
>"Side affects may case dry mouth, sleeplessness,"
>
>and then they quick ramble the bad ones...
>
>"abdominal paid, cramping, constipation, diareha..."
>
>Ummm... I think I can handle the asthma... thanks for the offer.


The one I like is for a new weight-loss drug:  "Since Losa-Pound works by
slowing absorption of fat globules, you may suffer bloating, gas, water
retention, urge to blast, explosive diarrhea, and inability to control
same.  Because your body doesn't have a chance to absorb necessary
nutrients, you'll need a multi-vitamin every day."

Uh, it sounds like a more extreme version of the symptoms they mentioned
for that fat substitute (Oelestra?) that came out a year or two back.  [In
that case the fat substitute is more like a soap than a fat... and soap is
known for the Symptoms mentioned above.]

--Paul E Musselman
PaulMmn@ix.netcom.com


+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---

This thread ...

Replies:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].